Interestingly, these mutants were exclusively localized as nuclear speckles in nearly 100% cells (S1 Fig), implying that cytoplasmic retention ability of SPOP may be impaired by prostate cancer-associated mutations. This evidence concerns the gene SPOP and prostate cancer.